Ethics and Human Cells

tktktktk

Return to main article:

“Harvard has been heavily involved in promoting regulatory oversight” of the use of human embryonic stem cells in research, says Insoo Hyun, director of the Center for Life Sciences and Public Learning at Boston’s Museum of Science and an affiliate of Harvard Medical School’s Center for Bioethics. Now, the importance of effective regulatory oversight matters more than ever, as burgeoning research into embryo models, which attempt to mimic the development of real embryos even though they are not derived from the fertilization of an egg, become a feature of laboratory science.

Through the Harvard Embryonic Stem Cell Research Oversight (ESCRO) committee and faculty leadership of organizations such as the International Society for Stem Cell Research (ISSCR), the University has been a leader in formulating and implementing ethical safeguards for the use of these cells. The ISSCR’s research guidelines have evolved in response to the changing scientific landscape, with significant revisions in 2006, 2008, 2016, and 2021. The stem-cell aggregates created in the Ramanathan lab, according to the 2021 vocabulary, are considered “non-integrated embryo models.” The term “non-integrated,” explains Hyun, “means that it is not the whole embryo that is being modeled.”

The vocabulary used to describe these models has evolved with the science. Because stem cells are routinely used to derive cell types that recapitulate organ development, the term “organoid” often appears in scientific papers. A more descriptive term, coined by Haas Foundations professor of linguistics Gennaro Chierchia during a 2018 discussion of nomenclature with Ann Kiessling (a member of the ESCRO committee and formerly an associate professor at Harvard Medical School), is “cellorg,” to denote an organ created from cells. Ramanathan uses the phrase “organized aggregate of stem cell derivatives that undergo morphogenesis” to describe his self-organizing neck-down models of the human body plan. (Ramanathan has chosen not to model the development of the head for ethical reasons.)

Non-integrated embryo models like Ramanathan’s do not require full committee review, according to the latest ISSCR guidelines. Harvard’s policy is to assess the moral and ethical dimensions of research using human embryonic stem cells on a case-by-case basis as part of a dialogue between researchers and the ESCRO committee. That group includes a legal expert, at least one bioethicist, a stem-cell scientist, a developmental biologist, an expert in artificial reproduction, and representatives from outside the University with relevant experience.

Though the terminology used to describe research sometimes becomes a battleground, the real question, says Hyun, is whether a model of an embryo carries moral weight. Often, sentience is the litmus test, which requires a brain. But there are other considerations. In Ramanathan’s case, his ability to reliably create large numbers of non-integrated embryo models is a “great step scientifically,” Hyun says, because it enables “outstanding experiments and has practical applications in drug development and industry.” At the same time, that “mass scale potential for creation,” he continues, could make some people uncomfortable. There’s that “fine line of wanting to do a lot of good by making tools to move forward scientifically and medically,” but weighed against “not wanting to over-instrumentalize or over-commercialize the human body….”

Read more articles by Jonathan Shaw
Related topics

You might also like

Five Questions with Andrew Knoll

A paleontologist on how to understand earth’s biggest extinction event

Harvard Professor Michael Sandel Wins Philosophy’s Berggruen Prize

The creator of the popular ‘Justice’ course receives a $1 million award.

Harvard Economist Wolfram Schlenker Is Tackling Climate Change

How extreme heat affects our land—and our food supply 

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

Harvard’s Endowment, Donations Rise—but the University Runs a Deficit

The annual financial report signals severe challenges to come.

Explore More From Current Issue

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

People gather near the John Harvard Statue in front of University Hall surrounded by autumn trees.

A Changed Harvard Faces the Future

After a tense summer—and with no Trump settlement in sight—the University continues to adapt. 

Students in purple jackets seated on chairs, facing away in a grassy area.

A New Prescription for Youth Mental Health

Kenyan entrepreneur Tom Osborn ’20 reimagines care for a global crisis.